Literature DB >> 11602856

Clearance of mobilized porcine peripheral blood progenitor cells is delayed by depletion of the phagocytic reticuloendothelial system in baboons.

M Basker1, I P Alwayn, L Buhler, D Harper, S Abraham, H Kruger Gray, H DeAngelis, M Awwad, J Down, R Rieben, M E White-Scharf, D H Sachs, A Thall, D K Cooper.   

Abstract

INTRODUCTION: Attempts to achieve immunological tolerance to porcine tissues in nonhuman primates through establishment of mixed hematopoietic chimerism are hindered by the rapid clearance of mobilized porcine leukocytes, containing progenitor cells (pPBPCs), from the circulation. Eighteen hours after infusing 1-2 x 10(10) pPBPC/kg into baboons that had been depleted of circulating anti-alphaGal and complement, these cells are almost undetectable by flow cytometry. The aim of the present study was to identify mechanisms that contribute to rapid clearance of pPBPCs in the baboon. This was achieved by depleting, or blocking the Fc-receptors of, cells of the phagocytic reticuloendothelial system (RES) using medronate liposomes (MLs) or intravenous immunoglobulin (IVIg), respectively.
METHODS: Baboons (preliminary studies, n=4) were used in a dose-finding and toxicity study to assess the effect of MLs on macrophage depletion in vivo. In another study, baboons (n=9) received a nonmyeloablative conditioning regimen (NMCR) aimed at inducing immunological tolerance, including splenectomy, whole body irradiation (300 cGy) or cyclophosphamide (80 mg/kg), thymic irradiation (700 cGy), T-cell depletion, complement depletion with cobra venom factor, mycophenolate mofetil, anti-CD154 monoclonal antibody, and multiple extracorporeal immunoadsorptions of anti-alphaGal antibodies. The baboons were divided into three groups: Group 1 (n=5) NMCR+pPBPC transplantation; Group 2 (n=2) NMCR+ML+pPBPC transplantation; and Group 3 (n=2) NMCR+IVIg+pPBPC transplantation. Detection of pig cells in the blood was assessed by fluorescence-activated cell sorter and polymerase chain reaction (PCR). PRELIMINARY STUDIES: ML effectively depleted macrophages from the circulation in a dose-dependent manner. Group 1: On average, 14% pig cells were detected 2 hr postinfusion of 1 x 10(10) pPBPC/kg. After 18 hr, there were generally less than 1.5% pig cells detectable. Group 2: Substantially higher levels of pig cell chimerism (55-78%) were detected 2 hr postinfusion, even when a smaller number (0.5-1 x 10(10)/kg) of pPBPCs had been infused, and these levels were better sustained 18 hr later (10-52%). Group 3: In one baboon, 4.4% pig cells were detected 2 hr after infusion of 1 x 10(10) pPBPC/kg. After 18 hr, however, 7.4% pig cells were detected. A second baboon died 2 hr after infusion of 4 x 10(10) pPBPC/kg, with a total white blood cell count of 90,000, of which 70% were pig cells. No differences in microchimerism could be detected between the groups as determined by PCR.
CONCLUSIONS: This is the first study to report an efficient decrease of phagocytic function by depletion of macrophages with MLs in a large-animal model. Depletion of macrophages with MLs led to initial higher chimerism and prolonged the survival of circulating pig cells in baboons. Blockade of macrophage function with IVIg had a more modest effect. Cells of the RES, therefore, play a major role in clearing pPBPCs from the circulation in baboons. Depletion or blockade of the RES may contribute to achieving mixed hematopoietic chimerism and induction of tolerance to a discordant xenograft.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602856     DOI: 10.1097/00007890-200110150-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  20 in total

Review 1.  CD47 in xenograft rejection and tolerance induction.

Authors:  Yong-Guang Yang
Journal:  Xenotransplantation       Date:  2010 Jul-Aug       Impact factor: 3.907

2.  Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages.

Authors:  Kentaro Ide; Hui Wang; Hiroyuki Tahara; Jianxiang Liu; Xiaoying Wang; Toshimasa Asahara; Megan Sykes; Yong-Guang Yang; Hideki Ohdan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

3.  Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells.

Authors:  Hui Wang; Maria Lucia Madariaga; Shumei Wang; Nico Van Rooijen; Per-Arne Oldenborg; Yong-Guang Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

Review 4.  T-cell-mediated immunological barriers to xenotransplantation.

Authors:  Joseph Scalea; Isabel Hanecamp; Simon C Robson; Kazuhiko Yamada
Journal:  Xenotransplantation       Date:  2012 Jan-Feb       Impact factor: 3.907

Review 5.  Innate cellular immunity and xenotransplantation.

Authors:  Hui Wang; Yong-Guang Yang
Journal:  Curr Opin Organ Transplant       Date:  2012-04       Impact factor: 2.640

6.  Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation.

Authors:  A Tena; J Kurtz; D A Leonard; J R Dobrinsky; S L Terlouw; N Mtango; J Verstegen; S Germana; C Mallard; J S Arn; D H Sachs; R J Hawley
Journal:  Am J Transplant       Date:  2014-10-02       Impact factor: 8.086

Review 7.  IXA Honorary Member Lecture, 2017: The long and winding road to tolerance.

Authors:  Megan Sykes
Journal:  Xenotransplantation       Date:  2018-05       Impact factor: 3.907

8.  Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.

Authors:  Chunfeng Wang; Hui Wang; Kentaro Ide; Yuantao Wang; Nico Van Rooijen; Hideki Ohdan; Yong-Guang Yang
Journal:  Cell Transplant       Date:  2011-04-29       Impact factor: 4.064

Review 9.  Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.

Authors:  Yong-Guang Yang
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

Review 10.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.